Vivacta Bio and Grit Bio's in vivo CAR-T therapy GT801 receives US FDA Orphan Drug Designation for autoimmune haemolytic anaemia

Viatris' RYZUMVI receives US FDA Approval to treat presbyopia

Omeros receives negative EU opinion on narsoplimab after re-examination

Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia

FDA approves Genentech's Enspryng as first at-home subcutaneous treatment for thyroid eye disease

Expression Therapeutics awarded USD2m grant to advance potential new therapy for children with high-risk neuroblastoma

EMA issues positive CHMP opinion for Revolution Medicines' RASONQUE in metastatic pancreatic cancer

Edesa Biotech receives FDA clearance to expand EB06 vitiligo study into the US

LTR Pharma launches Roxus nasal spray for ED in the US

Genezen agrees manufacturing collaboration with Galibra Neuroscience

FDA grants Breakthrough Therapy Designation to Legacy Healthcare's CINAINU (LH-8)

FDA approves Vantis Vascular's 6F CrossFAST model

Blue Lake Biotechnology reports interim data from Phase 1/2a paediatric clinical trial of BLB201

ArkBio reports FDA clearance of IND application for AK0406

Agilent to acquire Proscia for up to USD270m to expand digital pathology capabilities